MedTrace Logo

Montmorency Cherry Supplementation, Sleep, and Inflammation

NCT05700643 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-09-08

No results posted yet for this study

Summary

This study will test the effects of Montmorency cherry supplementation on sleep outcomes and inflammatory biomarkers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Montmorency cherry supplement

Montmorency cherry supplement

DIETARY_SUPPLEMENT

Control

Placebo

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-18
Primary Completion
2024-04-17
Completion
2024-04-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05700643 on ClinicalTrials.gov